Martin-Martin, A.; Rivera-Dictter, A.; Muñoz-Uribe, M.; López-Contreras, F.; Pérez-Laines, J.; Molina-BerrÃos, A.; López-Muñoz, R.
Reconsidering the Role of Cyclooxygenase Inhibition in the Chemotherapeutic Value of NO-Releasing Aspirins for Lung Cancer. Molecules 2019, 24, 1924.
https://doi.org/10.3390/molecules24101924
AMA Style
Martin-Martin A, Rivera-Dictter A, Muñoz-Uribe M, López-Contreras F, Pérez-Laines J, Molina-BerrÃos A, López-Muñoz R.
Reconsidering the Role of Cyclooxygenase Inhibition in the Chemotherapeutic Value of NO-Releasing Aspirins for Lung Cancer. Molecules. 2019; 24(10):1924.
https://doi.org/10.3390/molecules24101924
Chicago/Turabian Style
Martin-Martin, Antonia, Andrés Rivera-Dictter, MatÃas Muñoz-Uribe, Freddy López-Contreras, Jorge Pérez-Laines, Alfredo Molina-BerrÃos, and Rodrigo López-Muñoz.
2019. "Reconsidering the Role of Cyclooxygenase Inhibition in the Chemotherapeutic Value of NO-Releasing Aspirins for Lung Cancer" Molecules 24, no. 10: 1924.
https://doi.org/10.3390/molecules24101924
APA Style
Martin-Martin, A., Rivera-Dictter, A., Muñoz-Uribe, M., López-Contreras, F., Pérez-Laines, J., Molina-BerrÃos, A., & López-Muñoz, R.
(2019). Reconsidering the Role of Cyclooxygenase Inhibition in the Chemotherapeutic Value of NO-Releasing Aspirins for Lung Cancer. Molecules, 24(10), 1924.
https://doi.org/10.3390/molecules24101924